Study to Investigate the Efficacy and Safety of an Oral Investigational Medication in Patients with Alopecia Areata

Last Updated:
12/18/2021
Status:
Recruiting
Country:
United States
Eligibility:
Age 18-70; Moderate-to-severe alopecia areata (≥25% and < 95% scalp hair loss)
Drug:
Etrasimod
Administration:
Oral
Sponsor: 
Arena Pharmaceuticals

A clinical research study is recruiting patients with moderate-to-severe alopecia areata for a study that evaluates the Safety and Efficacy of an investigational drug. 

The study consists of an investigational oral drug that will be administered once daily, for 24 weeks. This investigational drug is experimental, and you will have 5 in 7 chances of receiving investigational drug and a 2 in 7 chance of receiving a placebo (an inactive pill). After the initial 24 weeks are completed, participants may receive the investigational drug for an additional 28 weeks where there will be no placebo.

Study Summary

During the study visits, several assessments and procedures will be conducted to assess your eligibility for the study. This study will last a period of up to 13 months and up to 17 visits.
Your participation in this study is at no cost to you. 

You may qualify to participate if you:

  • are between 18 and 70 years old
  • have alopecia areata
  • have ≥25% and <95% scalp hair loss*
    * This will be reviewed with the investigator

  • Other eligibility criteria apply


Click here to see if you qualify or contact the most convenient trial site listed below:

Investigate MD
Scottsdale, AZ, USA
Phone: 480-440-5985

California Dermatology & Clinical Research Institute
Encinitas, CA, USA
Phone: 760-203-3839

First OC Dermatology
Fountain Valley, CA, USA
Phone: 714-531-2966

University of California Irvine
Irvine, CA, USA
Phone: 949-824-7103

Stanford University
Redwood City, CA, USA
Phone: 650-497-3884

Yale School of Medicine
New Haven, CT, USA
Phone: 203-785-5182

Torrance Clinical Research Institute, Inc.
Lomita, FL, USA
Phone: 424-203-8983

Advanced Clinical Research Institute
Tampa, FL, USA
Phone: 813-362-1037

Advanced Medical Research
Sandy Springs, GA, USA
Phone: 404-939-9220

Dawes Fretzin Clinical Research Group, LLC
Indianapolis, IN, USA
Phone: 317-516-5030

Physicians Research Group
West Lafayette, IN, USA
Phone: 480-349-3412

Lawrence J Green, MD LLC
Rockville, MD, USA
Phone: 301-610-0663

Michigan Center For Skin Care Research
Clinton Township, MI, USA
Phone: 586-286-7325

Bobby Buka MD PC
New York, NY, USA
Phone: 212-385-3700 ext 1208

MediSearch Clinical Trials
St. Joseph, MO, USA
Phone: 816-364-1515

Skin Search of Rochester, Inc.
Rochester, NY, USA
Phone: 585-697-1818

Wilmington Dermatology Center
Wilmington, NC, USA
Phone: 910-256-4350

Central Sooner Research
Norman, OK, USA
Phone: 405-329-0474

NW Dermatology Institute
Portland, OR, USA
Phone: 503-223-1933

UPMC Department of
Dermatology

Pittsburgh, PA, USA
Phone: 412-647-5633

International Clinical Research - Tennessee LLC
Murfreesboro, TN, USA
Phone: 615-410-3460

Progressive Clinical Research
San Antonio, TX, USA
Phone: 210-614-5557

The Education & Research
Foundation, Inc.

Lynchburg, VA, USA
Phone: 434-847-8400

Dermatology Specialists of Spokane
Spokane, WA, USA
Phone: 509-496-2782

Laser Rejuvenation Dermatology
Clinics Edmonton D.T. Inc.

Edmonton, AB, Canada
Phone: 780-425-1212

Innovaderm Research
Montréal, QC, Canada
Phone: 514-521-3111 ext. 313

Dermatology Research Institute
Calgary, Alberta, Canada T2J 7E1
Phone: 403-263-3376